Professor Mari Dezawa graduated from Chiba University School of Medicine, Chiba, Japan, in 1989, was awarded the degree of MD, and worked as a resident in the Department of Internal Medicine at Chiba University Hospital. She started Neural Regeneration Research at the Department of Histology, Chiba University Graduate School of Medicine, was awarded her PhD in 1995, and continued her studies at Yokohama City University.

After moving to Kyoto University Graduate School of Medicine as Associate Professor in 2003, she developed methods to induce human mesenchymal stem cells (MSCs) to form neural and skeletal muscle cells (J. Clin. Invest, 2004; Science, 2005).

In 2008, she was appointed Professor and Chair of the Department of Stem Cell Biology and Histology at Tohoku University Graduate School of Medicine, where she discovered reparative pluripotent stem cells, Multilineage-Differentiating Stress Enduring (MUSE) stem cells, residing in the body (PNAS, 2010; PNAS, 2011; Nat Protocol, 2013; Cell Mol Life Sci, 2022).

Her team conducted pre-clinical studies for MUSE stem cells (Stroke, 2017; JASN, 2017; Cir Res, 2018; Mol Ther, 2020; Am J Transpl, 2021; JCBFM, 2021; J Invest Dermatol. 2021) and conducted clinical studies for their application in acute myocardial infarction, subacute stroke, amyotrophic lateral sclerosis, epidermolysis bullosa, neonatal hypoxic-ischemic encephalopathy, and cervical spinal cord injury (Stem Cell Transl Med, 2024).

She has been awarded several prizes, including the Prize for The Commendation for Science and Technology, Japan Government (2011). In 2018, she was appointed a fellow of the National Academy of Inventors (NAI) in the USA.

Dr. Christopher C. Dodson is head of Orthopaedics at the world renowned Vincera Institute in Philadelphia, Pennsylvania. He is a nationally recognized sports medicine surgeon known for caring for elite and professional athletes, while also helping active individuals return safely and confidently to performance.

Dr. Dodson has previously served as head team physician for the Philadelphia 76ers and Associate Head Orthopaedic Surgeon for the Philadelphia Eagles. He is currently a consultant to the National Hockey League (NHL) as well as several professional and collegiate teams. Dr. Dodson has authored over 100 articles and book chapters related to sports medicine and has been consistently recognized as a “Top Doctor” in the country. 

Kathleen O’Neil, MD, FAARM is a physician specializing in regenerative, integrative, and longevity medicine and the Founder and Medical Director of Treat Wellness, a Boston-based clinic focused on personalized diagnostics, hormone optimization, and regenerative therapies. She earned her MD from Boston University School of Medicine (Magna Cum Laude, Alpha Omega Alpha) and completed her Internal Medicine training at Brigham and Women’s Hospital.

Dr. O’Neil has been a leader in personalized and regenerative medicine for nearly two decades. She serves as a founding board member of the American Academy of Stem Cell Physicians and the International Peptide Society and lectures internationally on regenerative therapies, longevity science, peptides, and precision medicine.

In addition to her clinical work, she has held academic appointments with Boston University and Tufts University Schools of Medicine and has served as a national faculty lecturer for leading diagnostic and clinical education organizations. Earlier in her career, she competed on the U.S. Olympic rowing team and later served as a coach for the program.

Dr. Rowan Paul, MD, is a globally recognized expert in Regenerative Orthopedics and Sports Medicine, with extensive experience caring for elite athletes, including members of the San Francisco 49ers and several Olympians. His clinical and research focus centers on autologous and allogeneic cell therapies, as well as advanced image-guided regenerative procedures.

A serial entrepreneur and founder of multiple companies in the regenerative and longevity space—including Launch Biosciences and Launch Regenerative. Dr. Paul is also a co-owner of TOBI Networks, Physical Longevity, and the RegenCore Method, where he helps drive the clinical translation and market adoption of emerging technologies.

Dr. Paul sits on the Scientific Boards of the Regenerative Medicine Orthopedic Society (RMOS), the Global Regenerative Academy (GRA), TOBI (The Orthobiologics Institute), and Databiologics. He is a board-certified Family and Sports Medicine physician, an active investor, and a board member across several ventures advancing the future of regenerative care.

He serves as a Professor at the Dartmouth Geisel School of Medicine and is the Fellowship Site Director for Sports Medicine at Stanford Healthcare. Dr. Paul is a graduate of Brown University and Stanford Healthcare.

Dr. Mahmood MB,ChB, MRCS, FRCS Tr&Orth, DABRM, FABRM, is a Consultant Orthopedic Trauma Surgeon and Regenerative & Longevity Medicine Specialist working in one of the UK’s leading Major Trauma Units. Fellowship-trained in Orthopedic Trauma Surgery, his clinical focus spans major trauma care, sports and tendon injuries, post-trauma reconstruction, and the use of orthobiologics to optimize musculoskeletal healing and functional recovery.

He has served as University Hospital Lead for Major Trauma Research since 2016, with interests including trauma outcomes, AI in healthcare, platelet-rich plasma (PRP), and advanced orthobiologics—particularly stem-cell and exosome-based approaches—across musculoskeletal indications, wound healing, and regenerative applications including aesthetic and hair restoration. He is an Honorary Senior Clinical Lecturer within the Institute of Inflammation & Ageing at the University of Birmingham and represents major trauma within the Institute of Translational Medicine.

Dr Mahmood holds the Diploma of the American Board of Regenerative Medicine and was the first UK practitioner awarded Fellowship of the Board, recognized by the American Society & Academy of Regenerative Medicine. He is a Scientific Advisory Board Member of the American Society of Regenerative Medicine, UK/EU Chapter Head of The World Institute of Regenerative Medicine, UK Representative to ESTES, and a Visiting Professor to UniMax (São Paulo) and the Max Planck Institute of Medical Sciences.

He founded and leads the UK-based Academy of Regenerative Medicine (thearm.co.uk), widely regarded as a premier European provider of accredited education and hands-on training in regenerative medicine. An expert in cell preparation and delivery techniques, he trains clinicians internationally across orthopedics, wound care, aesthetics, dentistry, gynecology, and veterinary practice.

A key differentiator in his practice is advanced ultrasound expertise: he performs treatments under ultrasound guidance to enhance precision, safety, and outcomes in minimally invasive regenerative procedures. A recognized innovator, he integrates evidence-based practice with emerging technologies—particularly AI and cell-based therapies—to push the frontiers of orthobiologics and regenerative care.

Dr. White is widely recognized as a leading expert in aging and regenerative medicine. He earned his Ph.D. from the Ansary Stem Cell Institute in the Division of Regenerative Medicine at Cornell University and completed postdoctoral training at the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine, where he published pioneering research on the role of peripheral nerve signaling in cardiac regeneration. Dr. White is the CEO and CSO of Neobiosis, a perinatal regenerative tissue research and manufacturing company, and also serves as CSO for Ways2Well. He is the Vice President and a member of the Board of Directors of the American College of Regenerative Medicine. Additionally, he serves on the scientific advisory boards of the Alliance for Longevity Initiatives (A4Li) and the Healthspan Action Coalition.

The government of the Bahamas appointed Dr. White to the Ethics Committee for the Longevity and Regenerative Therapy Act (LARTA). He is also the founder of the Space-Aging Research Institute (SARI).

Dr. Vijay Vad is double board certified in physical medicine and rehabilitation (physiatry) and sports medicine. He focuses on minimally-invasive integrative treatments for sports injuries, knee arthritis and back pain via advanced Stem Cell therapies.

In addition to treating patients at the prestigious Hospital for Special Surgery out of NYC, Dr. Vad has previously served as the physician for the professional men’s tennis circuit (Association of Tennis Professionals, ATP) as well as the physician for the Westchester Classic of the PGA Tour, and MSG Tennis Showdown. Dr. Vad has written and published Back Rx, Arthritis Rx, Golf Rx and The New Rules of Running published by Penguin Random House.

In 2005, Dr. Vad’s bestseller Back Rx, was named the Wall Street Journal’s favorite health book of the year. He also authored two PBS national televisions specials entitled, ‘Stop Back Pain’ which premiered in June of 2011, and ‘Active with Arthritis’ which premiered in June of 2013.

As a researcher who constantly champions better treatments, Dr. Vad utilizes carboplasty which he has developed in conjunction with his colleagues in India, Ghana, and Germany. Through his use of tibial bone marrow-derived stem cells to treat knee arthritis he has minimized dependence on joint replacements, exhibiting promising results presented at the Orthopedic Research Society meeting, 2018.

Along with his scientific team in Boston, Dr. Vad has developed medical food capsules for dietary management of big diseases and to reduce dependence on anti-inflammatory medications and narcotics. His team has produced a highly absorbable curcumin called microactive plus curcumin, for managing arthritis and back pain.

Dr. Vad is the founder of the Vad Foundation, dedicated to educating disadvantaged girls globally and to medical research in the area of back pain and arthritis.

Dr. Joseph Purita is a board-certified orthopedic surgeon with over 20 years of expertise in cellular and anti-aging therapies within regenerative medicine. He completed his undergraduate and medical education at Georgetown University. Dr. Purita has lectured extensively across the globe on topics related to cellular therapies and anti-aging advancements, including discussions on heat & cold shock proteins, EBO2, ozone therapy, and intermittent hypoxia therapy.

Dr. Joseph Purita is recognized as one of the world’s foremost experts in Ozone Therapy and EBO2 (Extracorporeal Blood Oxygenation & Ozonation). With decades of clinical experience, he has pioneered many of the advancements in these regenerative treatments, utilizing them to address a wide range of conditions. His groundbreaking work in ozone therapy has garnered global attention. He recently spoke at his 200th conference, sharing his deep expertise with other leading medical professionals.

As the inaugural president of the American Academy and Board of Regenerative Medicine, he has played a pivotal role in shaping the field. Dr. Purita serves as the medical director of PUR-FORM, guiding innovative wellness and regenerative medicine programs with his vast experience. Dr. Purita also serves on scientific boards for a number of corporations.

In addition to publishing numerous scientific articles and book chapters, Dr. Purita was recently appointed as a Professor of Regenerative Medicine at the University of Max Planck in Indutuba, Brazil.

John Layke, DO, is a double-Board Certified plastic surgeon by the American Board of Surgery and the American Board of Plastic Surgery, renowned for his expertise in facial aesthetics as co-founder of the Beverly Hills Plastic Surgery Group. After graduating medical school and completing his General Surgery residency, he trained in Plastic and Reconstructive Surgery at Nassau University Medical Center in New York under the prestigious Long Island Plastic Surgical Group, the largest and oldest private practice group in America.

As Chief Medical Officer for Proactive Longevity, a forward-thinking company specializing in anti-aging treatment protocols, Dr. Layke has leveraged his passion for aesthetics to create Beverly Hills MD, an innovative skincare line blending cutting-edge dermal technology with natural ingredients. His decades of research and dedication to the aesthetics of aging led him toco-create STEM (Solutions Through Evolving Medicine), a regenerative medicine organization utilizing stem cells for their anti-aging properties, empowering patients to take control of their health and wellness. Dr. Layke has committed his medical career to discovering ways to “turnback the clock,” combining aesthetic procedures with regenerative medicine to enhance both appearance and functional performance beyond current expectations. His current research protocol shows promising evidence of recreating patients’ youthful dermal infrastructure. STEM’s partnership with Proactive Longevity further advances these innovative anti-aging solutions.

Dr. Layke also serves as the Medical Director for PureRx, a wellness group specializing in hormone optimization and peptide therapy. He has published in multiple medical and surgical journals and is a sought-after speaker for several cutting-edge biotechnology companies. Additionally, he serves on the Advisory Board for Neodyne Biosciences, known for state-of-the-art advanced scar therapy from Stanford University.

Harry Adelson, N.D. was an early adopter of the use of stem cells for the treatment of chronic musculoskeletal pain, establishing himself as a leading voice in the field of regenerative medicine. He began his specialized training in regenerative injection therapy (prolotherapy) in 1998 during his final year at the National University of Natural Medicine in Portland, Oregon.

His commitment to clinical excellence and service was further refined during his residency in Integrative Medicine at the Yale-Griffin Prevention Research Center. During this time, he volunteered at a large homeless shelter in Bridgeport, Connecticut, providing regenerative therapies to medically underserved populations at no cost while gaining the foundational experience that would define his career.

In 2002, Dr. Adelson opened Docere Clinics in Salt Lake City. From its inception, his practice has been 100% dedicated to regenerative injection therapies for musculoskeletal pain. Soon after moving his practice to Park City, Utah, he learned to aspirate and concentrate stem cells from bone marrow in 2010, from fat in 2012, and he began using umbilical cord cellular tissue products in 2022. To date, he has performed over 10,000 stem cell procedures and has injected stem cells into over 2,000 intervertebral discs, placing him among the most clinically experienced practitioners globally for the treatment of spinal pain.

Dr. Adelson is the innovator of the Full-Body Stem Cell Makeover® and currently serves as a Cofounder and the Chief Regenerative Medicine Officer of Humanaut Health. In 2020, he was the proud recipient of the “Above All, Patients First” Lifetime Achievement Award from the Cell Surgical Network. He continues to practice, rock climb, ski, and snow kite in beautiful Park City, Utah, where he lives with his wife and two daughters.

Dr. Deepti Agarwal is a triple board-certified physician whose work bridges clinical medicine, precision diagnostics, and advanced strategies for extending healthspan. Trained at Northwestern University’s Feinberg School of Medicine and Weill Cornell Medical Center, her career spans perioperative care, interventional procedures, metabolichealth, and the science of aging.

Her precision-medicine approach brings together multi-omic biomarkers, hormone and immune regulation, metabolic resilience, and regenerative therapeutics. After years caring for complex surgical and chronic pain patients, she developed a systems-level perspective on how inflammation, hormonal transitions, and reduced physiologic reserve influence health and aging. Her current work focuses on cardiometabolic dysfunction, hormonal transitions in midlife, musculoskeletal degeneration, and women’s brain and cognitive health.

Dr. Agarwal directs patient care at Precision Medical Care’s boutique Chicago practice and serves as an advisor to global healthspan organizations and emerging biotech ventures. She is committed to advancing the field of healthspan medicine by translating evolving scientific insights into clinical practice. Her work aims to help individuals and organizations reimagine what it means to age with capability, vitality, and long-term well-being.

Dr. Cook is a global thought leader, educator, and innovator in regenerative medicine, combining cutting-edge, non-surgical medicine and integrative care to harness the body’s natural healing power. Capable of addressing the most challenging conditions, his proprietary multimodal approach regenerates, repairs, and restores health on a cellular level. Dr. Cook is the founder of BioReset® Medical and BioReset® International. Dr. Cook is a pioneering regenerative medicine expert with over 20 years of experience practicing medicine, focusing the last 14 years on functional and regenerative medicine.

He graduated from the University of Washington School of Medicine, completed his residency in anesthesiology at the University of California San Francisco (UCSF), and completed fellowships in Anti-Aging, Metabolic and Functional Medicine, and Peptide Therapy with the American Academy of Anti-Aging Medicine. He is currently a member of the Peptide Therapy fellowship faculty.

His early career as an anesthesiologist and medical director of an outpatient surgery center specializing in sports medicine and orthopedic procedures provided valuable training in the skills needed to become a leader in the emerging field of Regenerative Medicine. Dr. Cook leverages minimally invasive treatments, believing that the body can heal itself naturally when supported by the best technology and care. While humanizing the doctor-patient relationship, he can assimilate a patient’s complex health history and develop highly specialized treatment plans integrating the best of what both functional and regenerative medicine have to offer.

A pioneering figure in the new field of regenerative urology, Dr. Ted Hoyda brings a wealth of expertise and innovation to MuseCell Innovations. His journey began with a prestigious background in Urologic Sciences, graduating from the University of British Columbia’s top-tier program in 2019.

Before working to shape the future of urology, Dr. Hoyda was pioneering advancements in neuroscience. His groundbreaking PhD work in Electroneurophysiology at Queen’s University in 2009 led to the development of a novel technology for measuring synaptic currents in living brain neurons while simultaneously detailing their unique molecular and genetic signatures. This work significantly enhanced our understanding of how hormones influence electrical signalling in the brain governing energy homeostasis. Following his PhD, Dr. Hoyda further honed his medical expertise at the Cumming School of Medicine, graduating in 2014.

Dr. Hoyda’s focus on Regenerative Urology is at the forefront of medical innovation. Utilizing a unique blend of stem cells, gene therapy, and biologics, his aim is to transform the treatment landscape for genitourinary tract diseases. By integrating state-of-the-art rejuvenation technologies, he is dedicated to enhancing the quality of life for all patients, pushing the boundaries of what’s possible in urologic health and longevity.

Dr. Hoyda’s personal mission is deeply rooted in the advancement of technology for challenging urologic conditions. His commitment to genital rejuvenation and the treatment of complex urologic diseases is unwavering. He envisions a future where rejuvenation technologies are not just accessible, but a cornerstone in enhancing peak physiology, longevity, and health span for his patients. With a passion for innovation and a dedication to excellence, Dr. Hoyda is not just practicing medicine; he is shaping the future of regenerative urology and committed to setting a new standard in patient care.

Jonathann Kuo, MD is Founder and CEO of Extension Health, a concierge longevity medicine practice in New York City and Miami. Double board-certified in anesthesiology and pain management with over 17 years of clinical experience, Dr. Kuo is an interventional regenerative medicine specialist focusing on image-guided therapies and advanced biologics including Dezawa MuseCells®.

Dr. Kuo has developed protocols that integrate the most advanced interventional longevity treatments with regenerative medicine. His practice focuses on human optimization and regenerative approaches to complex medical conditions.

Dr. Kuo has lectured extensively across the globe on peptides and regenerative medicine and has multiple publications on interventional techniques. He maintains hospital affiliations at Mount Sinai and Northwell Health and serves as a scientific advisor to the Enhanced Games. His clinical approach emphasizes mechanism-driven medicine, evidence-based precision, and advancing therapeutically validated interventions in regenerative and longevity medicine.

Dr. J. Omar Novelo-Baeza, MD, is a regenerative medicine specialist in family medicine and pediatrics with more than a decade of experience advancing the field, with a primary focus on pediatric neuroregeneration. As Medical Director of Neorgana Regenerative, his mission is to restore neurological function, improve quality of life, and unlock the body’s innate healing potential through minimally invasive, science-backed cellular therapies. Dr. Novelo-Baeza holds one of the highest levels of clinical expertise worldwide in the application of Dezawa MuseCells® for pediatric patients, treating multiple pediatric patients each week with complex neurological conditions using this advanced regenerative technology. He is actively building a dedicated platform to expand access, standardize protocols, and advance research around MuseCell-based therapies for pediatric populations — work that positions him at the forefront of the next generation of regenerative pediatric care.

A trusted leader in advanced regenerative protocols, Dr. Novelo-Baeza has dedicated his career to treating some of the most challenging conditions in modern medicine, including pediatric neurological disorders, neurodegenerative diseases, and autoimmune conditions where conventional approaches often fall short. He earned his medical degree from the Universidad Autónoma de Yucatán (UADY) and gained foundational clinical experience during his early years at the Hospital Infantil de México, one of Latin America’s most prestigious pediatric institutions. Building on that foundation, he has developed deep expertise in regenerative family and pediatric medicine, bridging cutting-edge cellular science with everyday clinical practice to offer patients evidence-based alternatives that prioritize healing at its biological source. Recognized for his compassionate, holistic approach, Dr. Novelo-Baeza blends scientific precision with genuine care, walking alongside each patient and family on their journey toward recovery and lasting wellness. 

Dr. Ram Dandillaya is a board-certified cardiologist, clinical researcher, and healthcare innovator with expertise in cardiovascular medicine, regenerative therapeutics, and longevity science. With more than 20 years of clinical experience, he leads programs focused on precision diagnostics, disease prevention, and healthy aging. He earned his medical degree from The George Washington University and completed his residency and fellowship training at Cedars-Sinai Medical Center and Harbor-UCLA Medical Center.

Formerly a Clinical Chief of Cardiology within the Cedars-Sinai Heart Institute, Dr. Dandillaya has dedicated his career to translating emerging scientific discoveries into meaningful clinical applications. His areas of focus include cellular therapies, age-related disease, metabolic health, artificial intelligence in medicine, and advanced cardiovascular imaging.

Dr. Dandillaya is a sought-after advisor in precision health, cardiac diagnostics, and longevity biotechnology. Through his clinical, research, and advisory work, he advances innovative, evidence-based strategies designed to improve healthspan, enhance quality of life, and help shape the future of medicine.